BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 24962838)

  • 1. A review of the application of inflammatory biomarkers in epidemiologic cancer research.
    Brenner DR; Scherer D; Muir K; Schildkraut J; Boffetta P; Spitz MR; Le Marchand L; Chan AT; Goode EL; Ulrich CM; Hung RJ
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1729-51. PubMed ID: 24962838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological Approaches Towards Cancer and Inflammation: A Cross Talk.
    Qu X; Tang Y; Hua S
    Front Immunol; 2018; 9():563. PubMed ID: 29662489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and Cancer.
    Venakteshaiah SU; Kumar KH
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):193-194. PubMed ID: 33596791
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammatory markers in cancer: Potential resources.
    Chauhan R; Trivedi V
    Front Biosci (Schol Ed); 2020 Jan; 12(1):1-24. PubMed ID: 31585862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the mediators of inflammation in cancer development.
    Fernandes JV; Cobucci RN; Jatobá CA; Fernandes TA; de Azevedo JW; de Araújo JM
    Pathol Oncol Res; 2015 Jul; 21(3):527-34. PubMed ID: 25740073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and cancer: how friendly is the relationship for cancer patients?
    Aggarwal BB; Gehlot P
    Curr Opin Pharmacol; 2009 Aug; 9(4):351-69. PubMed ID: 19665429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Biomarkers, Metabolism and Risk of Cancer: An Epidemiological Perspective.
    Nimptsch K; Pischon T
    Recent Results Cancer Res; 2016; 208():199-217. PubMed ID: 27909909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators.
    Ben-Baruch A
    Semin Cancer Biol; 2006 Feb; 16(1):38-52. PubMed ID: 16139507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation in sporadic colorectal cancer.
    Moossavi S; Bishehsari F
    Arch Iran Med; 2012 Mar; 15(3):166-70. PubMed ID: 22369306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying chronic inflammation-associated cancers.
    Wu Y; Antony S; Meitzler JL; Doroshow JH
    Cancer Lett; 2014 Apr; 345(2):164-73. PubMed ID: 23988267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation and cancer: an ancient link with novel potentials.
    Hussain SP; Harris CC
    Int J Cancer; 2007 Dec; 121(11):2373-80. PubMed ID: 17893866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammation: gearing the journey to cancer.
    Kundu JK; Surh YJ
    Mutat Res; 2008; 659(1-2):15-30. PubMed ID: 18485806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteinyl leukotrienes and their receptors: bridging inflammation and colorectal cancer.
    Savari S; Vinnakota K; Zhang Y; Sjölander A
    World J Gastroenterol; 2014 Jan; 20(4):968-77. PubMed ID: 24574769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into chronic inflammation-induced immunosuppression.
    Kanterman J; Sade-Feldman M; Baniyash M
    Semin Cancer Biol; 2012 Aug; 22(4):307-18. PubMed ID: 22387003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Sphingosine-1-Phosphate and Ceramide-1-Phosphate in Inflammation and Cancer.
    Hait NC; Maiti A
    Mediators Inflamm; 2017; 2017():4806541. PubMed ID: 29269995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging drives organ-specific alterations of the inflammatory microenvironment guided by immunomodulatory mediators in mice.
    Schädel P; Troisi F; Czapka A; Gebert N; Pace S; Ori A; Werz O
    FASEB J; 2021 May; 35(5):e21558. PubMed ID: 33855766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.
    Tampa M; Mitran MI; Mitran CI; Sarbu MI; Matei C; Nicolae I; Caruntu A; Tocut SM; Popa MI; Caruntu C; Georgescu SR
    J Immunol Res; 2018; 2018():1061780. PubMed ID: 30539028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory mediators hold the key to dendritic cell suppression and tumor progression.
    Sheng KC; Wright MD; Apostolopoulos V
    Curr Med Chem; 2011; 18(36):5507-18. PubMed ID: 22172061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cytokine-mediated link between innate immunity, inflammation, and cancer.
    Lin WW; Karin M
    J Clin Invest; 2007 May; 117(5):1175-83. PubMed ID: 17476347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory signaling and cellular senescence.
    Ren JL; Pan JS; Lu YP; Sun P; Han J
    Cell Signal; 2009 Mar; 21(3):378-83. PubMed ID: 18992324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.